105 related articles for article (PubMed ID: 8354302)
1. Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.
Barry AL; Pfaller MA; Fuchs PC; Tenover FC; Reller LB; Allen SD; Hardy DJ; Gerlach EH
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):352-6. PubMed ID: 8354302
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility testing quality control studies with fosfomycin tromethamine.
Fuchs PC; Barry AL; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of disk susceptibility testing of fosfomycin tromethamine.
Pfaller MA; Barry AL; Fuchs PC
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):67-70. PubMed ID: 8359009
[TBL] [Abstract][Full Text] [Related]
4. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Thornsberry C; Gavan TL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
[TBL] [Abstract][Full Text] [Related]
5. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
Fuchs PC; Jones RN; Barry AL; Gavan TL
J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
[TBL] [Abstract][Full Text] [Related]
6. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods.
Fuchs PC; Barry AL; Brown SD
J Antimicrob Chemother; 1999 Jan; 43(1):137-40. PubMed ID: 10381112
[TBL] [Abstract][Full Text] [Related]
7. Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.
Barry AL; Fuchs PC; Allen SD; Tenover FC; Jorgensen JH; Reller LB
J Clin Microbiol; 1995 Jan; 33(1):235-8. PubMed ID: 7699050
[TBL] [Abstract][Full Text] [Related]
8. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
Barry A; Fuchs P; Tenover F; Allen S; Hardy D; Jorgensen J; McLaughlin J; Reller L
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):822-6. PubMed ID: 7889952
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing.
Kronvall G
J Clin Microbiol; 1982 Nov; 16(5):784-93. PubMed ID: 6818249
[TBL] [Abstract][Full Text] [Related]
10. Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay.
Pitkin DH; Sheikh W; Nadler H
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():251-8. PubMed ID: 2808211
[TBL] [Abstract][Full Text] [Related]
11. Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
Tempera G; Mirabile M; Mangiafico A; Caccamo M; Bonfiglio G
J Chemother; 2004 Apr; 16(2):216-7. PubMed ID: 15216960
[No Abstract] [Full Text] [Related]
12. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
Aykut Arca E; Karabiber N
Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
[TBL] [Abstract][Full Text] [Related]
13. International collaborative study on standardization of bacterial sensitivity to fosfomycin.
Andrews JM; Baquero F; Beltran JM; Canton E; Crokaert F; Gobernado M; Gomez-Ius R; Loza E; Navarro M; Olay T
J Antimicrob Chemother; 1983 Oct; 12(4):357-61. PubMed ID: 6643331
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial spectrum of fosfomycin trometamol.
Barry AL; Brown SD
J Antimicrob Chemother; 1995 Jan; 35(1):228-30. PubMed ID: 7768774
[No Abstract] [Full Text] [Related]
15. Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group.
Jones RN; Kugler KC; Erwin ME; Biedenbach DJ; Beach ML; Pfaller MA
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):247-53. PubMed ID: 10212751
[TBL] [Abstract][Full Text] [Related]
16. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1998 Sep; 32(1):55-64. PubMed ID: 9791759
[TBL] [Abstract][Full Text] [Related]
18. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
Kronvall G
J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
[TBL] [Abstract][Full Text] [Related]
19. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the activity of the trometamol salt of fosfomycin.
Greenwood D; Jones A; Eley A
Eur J Clin Microbiol; 1986 Feb; 5(1):29-34. PubMed ID: 3084242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
